Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes

Aline Frick, Grace Blest‐hopley, Manesh Grin, David Erritzøe, David Nutt, Robin Carhart-Harris

Research Square June 19, 2026 Peer reviewed DOI: 10.21203/rs.3.rs-9880403/v1 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Escitalopram Psilocybin Anhedonia Randomized controlled trial Antidepressant

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
Negative affective bias in depression following treatment with psilocybin or escitalopram – a secondary analysis from a randomized trial Translational Psychiatry • November 13, 2025 • via OpenAlex
Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD February 11, 2026 • via OpenAlex
The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence Zenodo (CERN European Organization for Nuclear Research) • January 26, 2026 • via OpenAlex
Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis Neuroscience & Biobehavioral Reviews • January 24, 2026 • via OpenAlex

Comments

No comments yet.

Log in to comment